News from octapharma usa A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Dec 04, 2018, 12:12 ET Octapharma USA Sponsored Bombardier Blood Presented by Denver Mountain Climber During Special Hometown Screening

Colorado mountain climber Chris Bombardier, the first person with hemophilia to climb Mount Everest and the Seven Summits, was back in his hometown...


Jul 16, 2018, 10:03 ET Octapharma USA Sponsors Educational National Conference for Type 3 Von Willebrand Disease Patients

Octapharma USA was the exclusive sponsor of the VWD Connect Foundation Conference, a four-day national program for patients with Type 3/severe Von...


May 09, 2018, 10:03 ET Octapharma USA Funds Only National Camp Exchange Program for Bleeding Disorders Community Camps

For the second consecutive year, Octapharma USA will serve as the Exclusive Sponsor of the nation's only National Camp Exchange (NCE) for the...


Apr 03, 2017, 10:00 ET Octapharma USA Grant Supports First National Conference for Type 3 von Willebrand Disease Patients

Octapharma USA has awarded an educational grant to the Global Blood Disorder Foundation (GBDF) to sponsor the first national conference for patients...


Feb 27, 2012, 10:30 ET Octapharma USA Submits BLA for octaplasLG®, a Therapy Targeting Adverse Transfusion Events

Octapharma USA has submitted its Biological License Application (BLA) for octaplasLG® to the U.S. Food and Drug Administration (FDA) with the goal of ...


Jan 11, 2012, 12:33 ET Octapharma USA Appoints Global Biopharmaceutical Executive David E. Holliday as Vice President of Commercial Development

HOBOKEN, N.J., Jan. 11, 2012 /PRNewswire/-- Octapharma USA today announced that David E. Holliday has joined the biopharmaceutical company as Vice...


Nov 04, 2011, 01:11 ET FDA Approves U.S. Market Return for octagam® Following Octapharma's Implementation of Enhanced Safety Measures

The U.S. Food and Drug Administration (FDA) yesterday cleared the way for the U.S. market return of octagam® [Immune Globulin Intravenous (human) 5%...


Oct 18, 2011, 11:51 ET Octapharma USA to Participate in Important Medical Meetings at AABB, NHF, ASHP and ASH

Octapharma USA will be participating in several important medical meetings over the next few months, including AABB's 64th Annual Meeting in San...


Jun 28, 2011, 10:31 ET Octapharma USA Sponsors International Advisory Board for Evaluating Treatment of Patients with von Willebrand Disease

Octapharma USA recently hosted an International Physician Advisory Board in New York City, bringing together medical experts from around the world...


Jan 24, 2011, 10:30 ET Octapharma USA Supports NHIA Educational Program for the Diagnosis and Management of von Willebrand Disease

An unrestricted grant from Octapharma USA supported the development of a Continuing Education (CE) initiative entitled the "The Diagnosis and...


Jan 18, 2011, 10:30 ET Octapharma Targets Primary Immune Deficiency Research With Grant for The Mount Sinai Medical Center

Octapharma USA today announced the second grant recipient of the Octapharma 25th Anniversary Grants Program is the Clinical Immunology Research...


Dec 08, 2010, 10:30 ET Octapharma Researchers Propose New Objective Criteria for Evaluating the Treatment of von Willebrand Disease

Octapharma USA researchers presented new stringent, objective criteria used in the evaluation of hemostatic efficacy in the treatment of von...


Dec 01, 2010, 10:30 ET Octapharma USA Focuses on Urgent Surgeries as FDA Approves octaplex® for Fast Track Development

The U.S. Food and Drug Administration (FDA) has approved Octapharma USA's Investigational New Drug Application for octaplex® (Human Prothrombin...


Nov 08, 2010, 10:30 ET Octapharma Supports VWD Educational Initiatives Launched at National Hemophilia Foundation Annual Meeting

Octapharma USA is proud to support educational initiatives for von Willebrand Disease (VWD), the most common inherited bleeding disorder, at the 62nd ...


Nov 01, 2010, 11:00 ET Octapharma Clinical Trial Begins in the U.S. and Germany Treating Hemophilia A Patients with First Recombinant Factor VIII Derived from a Human Cell-Line

Octapharma AG, one of the largest human protein products manufacturers in the world, and Octapharma USA today announced that patients diagnosed with...


Oct 14, 2010, 11:00 ET Octapharma Accepting Applications for Research Grants Focused on Human Protein Therapies

Octapharma USA is accepting applications for the Octapharma 25th Anniversary Grants Program, which supports clinical or pre-clinical research focused ...


Oct 04, 2010, 10:30 ET Octapharma USA Launches Web Resource for von Willebrand Disease Healthcare Professionals and Patients

Octapharma USA has launched a comprehensive Web site for wilate® at www.wilateusa.com to provide von Willebrand disease healthcare professionals and...


Aug 12, 2010, 04:00 ET FDA conferma l'approvazione dell'esclusività quale farmaco orfano per il wilate(R), la nuova terapia di Octapharma USA per i disturbi ematici comuni di origine ereditaria

- L'approvazione offre sette anni di esclusività per il marketing da parte dell'FDA Octapharma USA ha ricevuto la conferma dell'esclusività quale...


Aug 12, 2010, 04:00 ET FDA bevestigt goedkeuring exclusiviteit weesgeneesmiddel wilate(R), de nieuwe behandeling van Octapharma USA voor erfelijke bloedingstoornis

- Goedkeuring levert zeven jaar aan FDA marketingexclusiviteit op Octapharma USA heeft van de Amerikaanse Food and Drug Administration (FDA)...


Aug 02, 2010, 09:00 ET FDA Confirms Orphan Drug Exclusivity Approval for wilate®, Octapharma USA's New Therapy for Common Inherited Bleeding Disorder

Octapharma USA has received confirmation of orphan drug exclusivity from the U.S. Food and Drug Administration (FDA) for wilate® (von Willebrand...


Aug 02, 2010, 05:00 ET FDA Confirma Exclusividade da Aprovação do Medicamento Órfão wilate(R), a Nova Terapia da Octapharma, nos EUA, para Doença de von Willebrand

- Aprovação Oferece Sete anos de Exclusividade de Marketing pelo FDA A Octapharma USA anunciou hoje que recebeu aprovação de exclusividade de...


Feb 04, 2010, 10:30 ET Octapharma Accepting Applications for Research Grants Through March 31

Octapharma USA will accept applications until March 31 for the Octapharma 25th Anniversary Grants Program, which supports clinical or pre-clinical...